Download Full Text (476 KB)


Background: Research shows that routine preoperative testing in elective low risk surgeries: Costs the U.S. an estimated $85.2 million annually; May add to patient’s personal financial burden; Does not improve patient outcomes; Clinically insignificant results can lead to delays in needed care prolonging pain and suffering and additional decompensation.

Clinically insignificant testing can also lead to a cascade of additional unnecessary testing.

PROBLEM STATEMENT: Unnecessary testing leads to increased cost and potential delays in care with no ROI (Return on Investment).

GOAL: Decrease unnecessary preoperative testing rates in patients undergoing any of 3 elective low risk surgeries (lap cholecystectomy, minor hernia repair, and breast lumpectomy) by 20% by the end of 2023.

Publication Date



Henry Ford Health


Detroit, Michigan


Quality Expo, posters, poster competition

Project #39: Appropriate Preoperative Screening in Low-Risk Surgeries



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.